T. Meijerhof

发表

University of Groningen Cross-protection induced by influenza: from infection to vaccines

L. Boon, G. Carnell, N. Temperton, 2018 .

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines

L. Boon, G. Carnell, N. Temperton, 2018, bioRxiv.

A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model.

M. Ökvist, A. Huckriede, T. Meijerhof, 2018, Virology.

Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration.

W. Hinrichs, H. Frijlink, J. Wilschut, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes.

J. Wilschut, A. Huckriede, T. Meijerhof, 2010, Vaccine.

Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses.

J. Wilschut, J. Regts, T. Daemen, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine.

Y. Bhide, A. Huckriede, J. de Vries-Idema, 2018, Biotechnology journal.

Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation

W. Hinrichs, H. Frijlink, A. Huckriede, 2017, Vaccines.

Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration

E. Gostick, J. Wilschut, A. Huckriede, 2013, Influenza and other respiratory viruses.

A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats

J. Wilschut, T. Stegmann, T. Meijerhof, 2013, Influenza and other respiratory viruses.

Evaluation of an Intranasal Virosomal Vaccine against Respiratory Syncytial Virus in Mice: Effect of TLR2 and NOD2 Ligands on Induction of Systemic and Mucosal Immune Responses

J. Wilschut, T. Meijerhof, M. Shafique, 2013, PloS one.

University of Groningen Evaluation of an Intranasal Virosomal Vaccine against Respiratory Syncytial Virus in Mice

J. Wilschut, T. Meijerhof, M. Shafique, 2013 .

Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation.

J. Wilschut, T. Stegmann, T. Meijerhof, 2010, Vaccine.

Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity

L. Boon, E. Gostick, J. Wilschut, 2012, PloS one.

Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.

B. Haijema, T. Meijerhof, K. Leenhouts, 2012, Vaccine.

Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination

Y. Bhide, A. Huckriede, J. de Vries-Idema, 2020, Immunity, inflammation and disease.

Experiences of using the cotton rat model for influenza vaccine evaluation

Y. Bhide, A. Huckriede, T. Meijerhof, 2018 .

Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7

T. Daemen, T. Meijerhof, N. van Rooij, 2015, Vaccines.

Critical Role of TLR7 Signaling in the Priming of Cross-Protective Cytotoxic T Lymphocyte Responses by a Whole Inactivated Influenza Virus Vaccine

L. Boon, E. Gostick, J. Wilschut, 2013, PloS one.

Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.

J. Wilschut, T. Stegmann, T. Meijerhof, 2013, Vaccine.

Enhanced Antiviral Activity of Human Surfactant Protein D by Site-Specific Engineering of the Carbohydrate Recognition Domain

M. Rynkiewicz, G. Rimmelzwaan, K. Hartshorn, 2019, Front. Immunol..

University of Groningen Development of adjuvanted influenza vaccines for pulmonary delivery

W. Hinrichs, H. Frijlink, A. Huckriede, 2017 .

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication

T. Daemen, T. Meijerhof, H. Nijman, 2015, Oncoimmunology.

Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice

J. Wilschut, T. Stegmann, T. Meijerhof, 2012, PloS one.

Critical Role of TLR7 Signaling in the Priming of Cross-Protective Cytotoxic T Lymphocyte Responses by a Whole Inactivated Influenza Virus Vaccine

L. Boon, E. Gostick, J. Wilschut, 2013, PloS one.

Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.

W. Hinrichs, H. Frijlink, J. Wilschut, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Short Communication Characterization of the functional requirements of West Nile virus membrane fusion

J. Smit, I. Rodenhuis-Zybert, J. Wilschut, 2010 .

Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion.

W. van Eden, B. Haijema, C. Keijzer, 2014, Vaccine.

University of Groningen Critical Role of TLR7 Signaling in the Priming of Cross-Protective Cytotoxic T Lymphocyte Responses by a Whole Inactivated Influenza Virus Vaccine Budimir,

L. Boon, E. Gostick, J. Wilschut, 2013 .

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization

L. Boon, D. Christensen, Y. Bhide, 2019, Front. Immunol..

New strategies for simplifying influenza vaccination

W. Hinrichs, H. Frijlink, A. Huckriede, 2014 .

Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants.

W. Hinrichs, H. Frijlink, T. Meijerhof, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.